Our patients include everyone from busy professionals in White Plains, to athletes in Rye Brook, to moms in Scarsdale who are focused on improving energy, recovery, and long-term health
10.3410/B5-1 649 UverskyV
Amylin receptor agonists represent an emerging class of obesity treatments distinct from glucagon-like peptide-1 (GLP-1) receptor agonists, with the potential for complementary or alternative therapeutic options for weight management
When prescribed and supervised by a qualified medical professional, peptide therapy is generally very safe
In senescent endothelial cells induced by OGD, treatment with FOXO4-DRI led to a significant increase in the expression of BAX and cleaved caspase-3 (c-Caspase-3), while the expression of BCL2 notably decreased
References Tchoumtchoua J, Mouchili OR, Ateba SB, Zingue S, Halabalaki M, Mbanya JC, et al